Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
96M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
32.2M
-
Shares change
-
+918K
-
Total reported value, excl. options
-
$3.3B
-
Value change
-
+$99.9M
-
Put/Call ratio
-
1.77
-
Number of buys
-
91
-
Number of sells
-
-52
-
Price
-
$102.39
Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q2 2015
170 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q2 2015.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.2M shares
of 96M outstanding shares and own 33.6% of the company stock.
Largest 10 shareholders include FMR LLC (5.38M shares), Capital Research Global Investors (4.4M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.33M shares), VANGUARD GROUP INC (1.74M shares), WELLINGTON MANAGEMENT GROUP LLP (1.67M shares), BlackRock Fund Advisors (1.32M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.18M shares), STATE STREET CORP (837K shares), WELLS FARGO & COMPANY/MN (829K shares), and JENNISON ASSOCIATES LLC (741K shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.